Transmission of surfactant protein variants and haplotypes in children hospitalized with respiratory syncytial virus

Pediatric Research

Volumn 66, Issue 1, 2009, Pages 70-73

  Thomas, Neal J ^a,d   Diangelo, Susan ^a   Hess, Joseph C ^a   Fan, Ruzong ^b   Ball, Margaret W ^c   Geskey, Joseph M ^a   Willson, Douglas F ^c   Floros, Joanna ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d PENN STATE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ARTICLE; CHILD; CONTROLLED STUDY; FAMILY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOMICS; HAPLOTYPE; HEREDITY; HIGH RISK PATIENT; HUMAN; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARENT; PRIORITY JOURNAL; PROGENY; PROTEIN TRANSPORT; PROTEIN VARIANT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS INFECTION; GENETIC PREDISPOSITION; GENETICS; INFANT; PRESCHOOL CHILD; PROSPECTIVE STUDY;

CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 70149121357     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181a1d768     Document Type: Article

References (42)

1. Kusel MM, de Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD 2006 Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J 25:680-686
2. Wolf DG, Greenberg D, Kalkstein D, Shemer-Avni Y, Givon-Lavi N, Saleh N, Goldberg MD, Dagan R 2006 Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children. Pediatr Infect Dis J 25:320-324
3. Hall CB 2001 Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344:1917-1928
4. Leader S, Kohlhase K 2003 Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 143:S127-S132
5. Holman RC, Curns AT, Cheek JE, Bresee JS, Singleton RJ, Carver K, Anderson LJ 2004 Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics 114:e437-e444
6. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K 2003 Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186 (Pubitemid 36068705)
7. Purcell K, Fergie J 2004 Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J 23:418-423
8. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR 2000 Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 137:865-870
9. Arnold SR, Wang EE, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, Langley JM, McDonald J, MacDonald NE, Mitchell I 1999 Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J 18:866-869
10. Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, Cohen HJ 1986 Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 315:77-81
11. Fjaerli HO, Farstad T, Bratlid D 2004 Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway 1993-2000: a population-based retrospective study. BMC Pediatr 4:25
12. Geskey JM, Thomas NJ, Brummel GL 2007 Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV). Biol Targets Ther 1:33-43
13. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B 2000 Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161:1501-1507
14. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD 1999 Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354:541-545
15. Carlsen KH, Larsen S, Orstavik I 1987 Acute bronchiolitis in infancy. The relationship to later recurrent obstructive airways disease. Eur J Respir Dis 70:86-92
16. Carlsen KH, Larsen S, Bjerve O, Leegaard J 1987 Acute bronchiolitis: predisposing factors and characterization of infants at risk. Pediatr Pulmonol 3:153-160
17. Puthothu B, Forster J, Heinzmann A, Krueger M 2006 TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease. Dis Markers 22:303-308
18. Hoebee B, Rietveld E, Bont L, Oosten M, Hodemaekers HM, Nagelkerke NJ, Neijens HJ, Kimpen JL, Kimman TG 2003 Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis 187:2-11
19. Wilson J, Rowlands K, Rockett K, Moore C, Lockhart E, Sharland M, Kwiatkowski D, Hull J 2005 Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis. J Infect Dis 191:1705-1709
20. Hull J, Rowlands K, Lockhart E, Moore C, Sharland M, Kwiatkowski D 2003 Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J Infect Dis 188:904-907
21. Lofgren J, Ramet M, Renko M, Marttila R, Hallman M 2002 Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 185:283-289 (Pubitemid 34107240)
22. Lahti M, Lofgren J, Marttila R, Renko M, Klaavuniemi T, Haataja R, Ramet M, Hallman M 2002 Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 51:696-699 (Pubitemid 34547331)
23. Floros J, Phelps DS 1997 Pulmonary surfactant. In: Yaksch TL, Lynch C, Maze M, Biebuyck JF, Saidman LJ (eds) Anesthesia: Biological Foundations. Lippincott-Raven, New York, pp 1257-1279
24. Phelps DS 1995 Pulmonary surfactant modulation of host-defense function. Appl Cardiopul Pathophysiol 5:221-229
25. Hoover RR, Floros J 1998 Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 18:353-362
26. Kerr MH, Paton JY 1999 Surfactant protein levels in severe respiratory syncytial virus infection. Am J Respir Crit Care Med 159:1115-1118
27. Levine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T 1999 Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 103:1015-1021
28. Barr FE, Pedigo H, Johnson TR, Shepherd VL 2000 Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages. Am J Respir Cell Mol Biol 23:586-592
29. Levine AM, Elliott J, Whitsett JA, Srikiatkhachorn A, Crouch E, DeSilva N, Korfhagen T 2004 Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol 31:193-199
30. Pavlovic J, Papagaroufalis C, Xanthou M, Liu W, Fan R, Thomas NJ, Apostolidou I, Papathoma E, Megaloyianni E, DiAngelo S, Floros J 2006 Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia. Dis Markers 22:277-291
31. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES 1996 Parametric and nonpara-metric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363
32. Sham PC, Curtis D 1995 An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 59:323-336
33. Floros J, Fan R, Matthews A, DiAngelo S, Luo J, Nielsen H, Dunn M, Gewolb IH, Koppe J, van Sonderen L, Farri-Kostopoulos L, Tzaki M, Ramet M, Merrill J 2001 Family-based transmission disequilibrium test (TDT) and case-control association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences. Clin Genet 60:178-187
34. Mikerov AN, Wang G, Umstead TM, Zacharatos M, Thomas NJ, Phelps DS, Floros J 2007 Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun 75:1403-1412
35. Thomas NJ, Fan R, DiAngelo S, Hess JC, Floros J 2007 Haplotypes of the surfactant protein genes A and D as susceptibility factors for the development of respiratory distress syndrome. Acta Paediatr 96:985-989
36. Ramet M, Haataja R, Marttila R, Floros J, Hallman M 2000 Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. Am J Hum Genet 66:1569-1579
37. Ramet M, Lofgren J, Alho OP, Hallman M 2001 Surfactant protein-A gene locus associated with recurrent otitis media. J Pediatr 138:266-268
38. Floros J, Hoover RR 1998 Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1408:312-322
39. Kolble K, Lu J, Mole SE, Kaluz S, Reid KB 1993 Assignment of the human pulmonary surfactant protein D gene (SFTP4) to 10q22-q23 close to the surfactant protein A gene cluster. Genomics 17:294-298
40. Liu W, Bentley CM, Floros J 2003 Study of human SP-A, SP-B and SP-D loci: allele frequencies, linkage disequilibrium and heterozygosity in different races and ethnic groups. BMC Genet 4:13
41. Puthothu B, Krueger M, Heinze J, Forster J, Heinzmann A 2006 Haplotypes of surfactant protein C are associated with common paediatric lung diseases. Pediatr Allergy Immunol 17:572-577
42. Puthothu B, Forster J, Heinze J, Heinzmann A, Krueger M 2007 Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus associated diseases. BMC Pulm Med 7:6